The role of extracellular matrix phosphorylation on energy dissipation in bone.Bailey S., Sroga G.E., Hoac B., Katsamenis O.L., Wang Z., Bouropoulos N., McKee M.D., Sorensen E.S., Thurner P.J., Vashishth D.View abstractCategoryPTM / ProcessingSourceMGI: 107489PubMedEurope PMCElife 9:e58184-e58184 (2020)Mapped to19
Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formation.Goetz R., Nakada Y., Hu M.C., Kurosu H., Wang L., Nakatani T., Shi M., Eliseenkova A.V., Razzaque M.S.[...], Mohammadi M.View abstractCategoryPTM / ProcessingSourceMGI: 107489PubMedEurope PMCProc. Natl. Acad. Sci. U.S.A. 107:407-412 (2010)Cited in1Mapped to45
Phosphorylation-dependent inhibition of mineralization by osteopontin ASARM peptides is regulated by PHEX cleavage.Addison W.N., Masica D.L., Gray J.J., McKee M.D.View abstractAnnotationOPN ASARM inhibits mineralization by binding to hydroxyapatite in a phosphorylation-dependent manner and can be cleaved by PHEX.CategoryPTM / ProcessingSourceGeneRif: 18675PubMedEurope PMCJ Bone Miner Res 25:695-705 (2010)Mapped to14
Inhibition of MEPE cleavage by Phex.Guo R., Rowe P.S., Liu S., Simpson L.G., Xiao Z.S., Quarles L.D.View abstractAnnotationMEPE may be involved in the pathogenesis defective mineralization due to Phex deficiency in X-linked hypophosphatemia (XLH) and the Hyp-mouse.CategoryPTM / ProcessingSourceGeneRif: 18675PubMedEurope PMCBiochem. Biophys. Res. Commun. 297:38-45 (2002)Cited in3Mapped to6